1. Home
  2. CBAT vs FBIO Comparison

CBAT vs FBIO Comparison

Compare CBAT & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBAT
  • FBIO
  • Stock Information
  • Founded
  • CBAT 1999
  • FBIO 2006
  • Country
  • CBAT China
  • FBIO United States
  • Employees
  • CBAT N/A
  • FBIO N/A
  • Industry
  • CBAT Industrial Machinery/Components
  • FBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBAT Miscellaneous
  • FBIO Health Care
  • Exchange
  • CBAT Nasdaq
  • FBIO Nasdaq
  • Market Cap
  • CBAT 90.4M
  • FBIO 88.7M
  • IPO Year
  • CBAT N/A
  • FBIO N/A
  • Fundamental
  • Price
  • CBAT $0.96
  • FBIO $2.99
  • Analyst Decision
  • CBAT
  • FBIO Strong Buy
  • Analyst Count
  • CBAT 0
  • FBIO 2
  • Target Price
  • CBAT N/A
  • FBIO $16.50
  • AVG Volume (30 Days)
  • CBAT 211.1K
  • FBIO 1.6M
  • Earning Date
  • CBAT 11-11-2025
  • FBIO 11-13-2025
  • Dividend Yield
  • CBAT N/A
  • FBIO N/A
  • EPS Growth
  • CBAT N/A
  • FBIO N/A
  • EPS
  • CBAT N/A
  • FBIO N/A
  • Revenue
  • CBAT $145,462,366.00
  • FBIO $59,301,000.00
  • Revenue This Year
  • CBAT N/A
  • FBIO $49.84
  • Revenue Next Year
  • CBAT $60.02
  • FBIO $42.47
  • P/E Ratio
  • CBAT N/A
  • FBIO N/A
  • Revenue Growth
  • CBAT N/A
  • FBIO N/A
  • 52 Week Low
  • CBAT $0.57
  • FBIO $1.33
  • 52 Week High
  • CBAT $1.30
  • FBIO $4.20
  • Technical
  • Relative Strength Index (RSI)
  • CBAT 53.61
  • FBIO 45.50
  • Support Level
  • CBAT $0.87
  • FBIO $2.72
  • Resistance Level
  • CBAT $1.02
  • FBIO $3.24
  • Average True Range (ATR)
  • CBAT 0.04
  • FBIO 0.29
  • MACD
  • CBAT 0.01
  • FBIO -0.13
  • Stochastic Oscillator
  • CBAT 50.00
  • FBIO 22.61

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: